Due to ongoing IV trace element shortages and the recent FDA approved importation of multi-trace and single element products, the A.S.P.E.N. Clinical Practice Committee's Nutrition Product Shortage Subcommittee conducted a survey this spring to learn more about how clinicians are managing the prolonged shortage of IV trace elements. The results of that survey are now available and some take away messages are included in this report. For questions on these results, contact
Beverly Holcombe, PharmD
in the A.S.P.E.N. office.